Join us at the AACR New Horizons in Cancer Research Conference

November 6-9, Shanghai, China

Don't miss our 4 posters covering a range of immuno-oncology topics including combination checkpoint inhibitor and targeted agent treatment of syngeneic cell lines and flow-based phenotyping of tumor-infiltrating immune cells in novel immuno-oncology in vivo models.

精準識別

一眼認出你的下一個臨床候選

中美冠科轉化醫學平臺能夠幫助客戶識別適合的治療方案用於合適的患者。無論是腫瘤學還是糖尿病相關疾病,擁有能夠更準確類比人類疾病的模型和群體動態的模型,是將候選化合物轉化為成功臨床候選藥物的關鍵。

開闊視野

瞭解疾病發生的機制

中美冠科敏銳的科學能力和豐富的經驗能給予您化合物的藥理學、以及有方向地去選擇哪些化合物進入臨床的深刻見解。您可以查閱我們發表的文獻來進一步瞭解我們科學經驗的深度。

洞察結果

將科學與患者相結合。

中美冠科通過回答一些關於人類生物學最挑戰的問題,協助客戶在解決腫瘤學、心血管以及代謝疾病上一些當前最緊迫的問題。

CVMD

肥胖模型

obesity-img.jpg

中美冠科生物臨床前轉化醫學技術派平臺提供自發及飼料誘導的肥胖模型(DIO),以支援新藥物進入臨床的轉化研究。

瞭解更多

腫瘤學 Oncology

腫瘤學資料庫Oncology Databases

databases-img.jpg

我們獨特的資料庫整合了我們充分研究的模型資訊,可以用於PDX模型,細胞系及同源模型的藥物研發專案。

瞭解更多

CVMD

糖尿病模型Diabetes Models

oncoexpress-img.jpg

用於抗糖尿病藥物體內藥效實驗的一型及二型糖尿病模型,包括市場上常見模型及我們獨有且具有高度轉化能力的模型。

瞭解更多

Latest from our Blog

October 19, 2017

Quick Guide: Top 3 AML Approval Trends for 2017

Acute myeloid leukemia has been the focus of much drug development, but few drug approvals, for the past few decades. While there have been significant research efforts into characterizing AML, and improving patient outcomes, the standard therapy for most subtypes of newly diagnosed AML has remained unchanged for the last 40 years.

Read More

October 19, 2017

Quick Guide: Top 3 AML Approval Trends for 2017

Acute myeloid leukemia has been the focus of much drug development, but few drug approvals, for...

Read More

October 17, 2017

The Role of Gut Microbiota and Implications for IBD

Over the past 10 years, scientists have discovered that changes in the composition of the gut...

Read More

October 12, 2017

Organ-on-a-Chip: The Future of Improved Drug Discovery?

I’m a firm believer in the use of animal models in medical research. This is so for many...

Read More

October 10, 2017

ADA 2017 Video Poster Review

Naturally Diabetic NHP Immune Cell Changes Correspond to Human Type 2 Diabetes

While changes in...

Read More

October 5, 2017

What's Next for Immune Checkpoint Inhibitors: TIM-3?

Unlike negative regulators, such as PD-1 and CTLA-4 (which have been proposed as therapeutic...

Read More

Upcoming Events


October 20 - 24, 2017

American Association for the Study of Liver Disease: The Liver Meeting® 2017

Washington D.C.

Learn More


October 26 - 30, 2017

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications

Booth #601, Philadelphia, PA

Learn More


November 6 - 9, 2017

4th AACR New Horizons in Cancer Research Conference: Research Propelling Cancer Prevention and Cures

Shanghai, China

Learn More


November 9 - 11, 2017

First EASL Nonalcoholic Fatty Liver Disease (NAFLD) Summit:

Rome, Italy

Learn More